Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Shares Down 4.9% - Time to Sell?

Key Points

• Senseonics shares fell 4.9% on Tuesday to $5.03, with trading volume 33% below the daily average. The move came after the stock had closed at $5.29.
• Analysts remain mixed but broadly constructive: HC Wainwright cut its target to $14 while keeping a buy rating, Stifel lowered its target to $8 and held, and Weiss Ratings downgraded the stock. Overall, MarketBeat shows a consensus of Moderate Buy with an average price target of $17.
• The company continues to post weak fundamentals, including a wider-than-expected quarterly loss of $0.71 per share and negative net margin and return on equity. Senseonics reported $11.71 million in revenue for the quarter and has a market cap of about $210 million.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS - Get Free Report)'s stock price traded down 4.9% on Tuesday . The company traded as low as $5.03 and last traded at $5.03. Approximately 573,880 shares traded hands during trading, a decline of 33% from the average daily volume of 858,881 shares. The stock had previously closed at $5.29.

Analysts Set New Price Targets

Several research analysts have issued reports on SENS shares. HC Wainwright lowered their price target on shares of Senseonics Holdings, Inc. Common Stock from $18.50 to $14.00 and set a "buy" rating for the company in a report on Tuesday, May 12th. Weiss Ratings lowered shares of Senseonics Holdings, Inc. Common Stock from a "sell (d-)" rating to a "sell (e+)" rating in a research note on Thursday, May 28th. Finally, Stifel Nicolaus decreased their price objective on shares of Senseonics Holdings, Inc. Common Stock from $9.00 to $8.00 and set a "hold" rating for the company in a research report on Monday, May 11th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $17.00.

Senseonics Holdings, Inc. Common Stock Stock Performance

The firm has a market cap of $210.25 million, a PE ratio of -2.52 and a beta of 0.99. The firm has a fifty day moving average of $6.12. The company has a debt-to-equity ratio of 1.05, a current ratio of 3.51 and a quick ratio of 3.19.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS - Get Free Report) last released its earnings results on Thursday, May 7th. The company reported ($0.71) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.65) by ($0.06). The company had revenue of $11.71 million for the quarter. Senseonics Holdings, Inc. Common Stock had a negative net margin of 213.87% and a negative return on equity of 129.97%. On average, sell-side analysts anticipate that Senseonics Holdings, Inc. Common Stock will post -2.38 earnings per share for the current year.

Insiders Place Their Bets

In related news, Director Douglas A. Roeder acquired 22,686 shares of the company's stock in a transaction dated Tuesday, May 12th. The shares were purchased at an average price of $5.56 per share, for a total transaction of $126,134.16. Following the completion of the acquisition, the director owned 144,635 shares of the company's stock, valued at approximately $804,170.60. This trade represents a 18.60% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 4.70% of the company's stock.

Institutional Trading of Senseonics Holdings, Inc. Common Stock

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Cetera Investment Advisers acquired a new position in shares of Senseonics Holdings, Inc. Common Stock during the first quarter worth approximately $85,000. Captrust Financial Advisors acquired a new stake in Senseonics Holdings, Inc. Common Stock in the 4th quarter valued at $77,000. Hudson Bay Capital Management LP acquired a new stake in Senseonics Holdings, Inc. Common Stock in the 4th quarter valued at $85,000. GSK plc bought a new stake in Senseonics Holdings, Inc. Common Stock during the 4th quarter valued at $60,000. Finally, Ausdal Financial Partners Inc. increased its stake in Senseonics Holdings, Inc. Common Stock by 50.0% during the 3rd quarter. Ausdal Financial Partners Inc. now owns 105,000 shares of the company's stock valued at $46,000 after purchasing an additional 35,000 shares in the last quarter. 12.36% of the stock is owned by institutional investors.

Senseonics Holdings, Inc. Common Stock Company Profile

Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.

Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.